RxDoctor Payments Data

Maureen Olivier, MD

Dermatology · Lake Charles, LANPI 1407906928

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 93.3% of the total across 107 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 19 manufacturers, the largest accounting for just 21.0% — the pattern of someone who eats at a lot of different presentations. That places this record below the midpoint for dermatology clinicians in LA, where the typical reported total is $5,293.

$2,632in general payments, 2019–2025

Across 107 payments — averaging $24.60 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Arcutis Biotherapeutics, Inc.$552
  • AbbVie$436
  • Novartis$297
  • Johnson & Johnson$274
  • Lilly USA, LLC$247
  • Hill Dermaceuticals, Inc.$176
  • plus $650 from 13 others
$552,795in research payments, 2019–2025

Across 82 payments — averaging $6741.41 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Janssen Research & Development, LLC$421K
  • Eli Lilly$63K
  • LEO Pharma AS$47K
  • Incyte Corporation$23K

What the payments were for

  • Food & beverage$2,45593%
  • Education$1777%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$2,632 in reported general payments places this provider in the 30th percentile of 189 dermatology providers in Louisiana.

See all dermatology providers in Louisiana

Medicare billing

Part B allowed, 2024
$195,872
Medicare patients
681
Services billed
3,320

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Taltz AutoinjectorIxekizumab16$128,258
Ketoconazole293$3,975
Fluocinonide68$2,901
Doxycycline Hyclate107$1,715
Clotrimazole-BetamethasoneClotrimazole/Betamethasone Dip87$1,626
Betamethasone Dipropionate43$1,279
Clobetasol Propionate42$1,069
Metronidazole29$970
Triamcinolone Acetonide64$800
Fluconazole45$363
Clindamycin Phosphate15$326
Minoxidil79$318
Minocycline Hcl12$287
Mometasone Furoate16$216
Terbinafine Hcl14$144

Paid to pharmacies, not to this prescriber.

Other dermatology in Lake Charles

See the full list for Louisiana

Where these figures come from

Is this you, or does something look wrong? →